Effect of Acute Caffeine and Beetroot Juice Intake on Strength, Power, and Muscular Endurance
CAF+BJ
1 other identifier
interventional
14
1 country
1
Brief Summary
Introduction: Several studies have evaluated and confirmed the ergogenic effect of acute caffeine and beetroot juice intake on sports performance. However, there are few studies focused on the production of strength, power, and muscle endurance, particularly when both supplements are ingested together. Objectives: Evaluate the acute effect of combined and isolated intake of caffeine and beetroot juice on the production of strength, power, and muscle endurance in young adults, analyzing the effect of circadian rhythms (morning vs. afternoon) on the exercise performed (bench press vs. squat). Methods: A total of 12 healthy and physically active participants will be recruited for the study. Through a double-blind, crossover, randomized, and controlled design, participants will ingest: a) Caffeine (3 mg/kg body mass); b) Beetroot juice (70 ml, 6.5 mmol of nitrates); c) Caffeine + Beetroot juice; d) Placebo (maltodextrin, 3 mg/kg). The supplements will be ingested 120 minutes (beetroot juice or placebo) and 60 minutes before (caffeine or placebo), the latter dissolved in 200 ml of water. After the ingestion period, strength, power, and muscle endurance will be analyzed with 1RM tests, strength and power tests at 25%, 50%, 75%, and 90% 1RM, and muscle endurance tests at 65% 1RM, in all cases for squat and bench press exercises. Additionally, dynamometry (manual and the isometric mid-thigh pull test) and vertical jump (squat jump and countermovement jump) will be analyzed. The four experimental conditions will be conducted in the morning (8:00 am to 10:00 am) and in the afternoon (4:30 pm to 6:30 pm).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2024
CompletedFirst Submitted
Initial submission to the registry
September 6, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedSeptember 19, 2024
September 1, 2024
5 months
September 6, 2024
September 10, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Mean and peak velocity and time to reach peak velocity at different %1RM
Measuring bar velocity desplacement during bench press and back squat exercises.
On each trial, after dietary supplement intake, during 2 weeks
Mean and peak power output and time to reach peak power output at different %1RM
Measuring power output generated during bench press and back squat exercises.
On each trial, after dietary supplement intake, during 2 weeks
Number of repetitions performed at 65%1RM until task failure
Additionally to mean and peak velocity, mean and peak power output, time to reach peak velocity and peak power
On each trial, after dietary supplement intake, during 2 weeks
Secondary Outcomes (4)
Mood state (tension, depression, anger, vigor, fatigue and confusion)
On each trial, after dietary supplement intake, during 2 weeks
Adverse effects
On each trial, after dietary supplement intake, during 2 weeks
handgrip and isometric mid-thigh pull tests
On each trial, after dietary supplement intake, during 2 weeks
Vertical Jump (cm and power)
On each trial, after dietary supplement intake, during 2 weeks
Study Arms (4)
Caffeine + Beetroot Juice
EXPERIMENTAL70 mL of concentrated NO3--rich (BJ, 6.5 mmol NO3-) + 3 mg/kg of caffeine
Beetroot Juice
EXPERIMENTAL70 mL of concentrated NO3--rich (BJ, 6.5 mmol NO3-) + 3 mg/kg of placebo (maltodextrin)
Caffeine
EXPERIMENTAL70 mL of NO3--depleted (BJ, 0.04 mmol NO3-) + 3 mg/kg of caffeine
Placebo
PLACEBO COMPARATOR70 mL of NO3--depleted (BJ, 0.04 mmol NO3-) + 3 mg/kg of placebo (maltodextrin)
Interventions
Combined effect of beetroot juice and caffeine intake on muscular strength, power and endurance performance
single effect of caffeine intake on muscular strength, power and endurance performance
single effect of beetroot juice intake on muscular strength, power and endurance performance
single effect of placebo on muscular strength, power and endurance performance
Eligibility Criteria
You may qualify if:
- Age between ≥ 18 and ≤ 35 years.
- Body Mass Index (BMI) \< 25 kg/m².
- Resistance-trained individuals (\> 2 years of structured trained).
- Healthy men and women without neurological, cardiometabolic, immunological, or physical conditions that prevent them from exercising.
- Participants must be able to perform the tests described in the following section.
You may not qualify if:
- History of neuromuscular diseases, heart diseases, or diseases that may affect liver or muscle metabolism.
- Use of drugs, other stimulants or sport supplements that interfere with the intake of the study\'s dietary supplements.
- Sedentary habits (\< 150 min/week of moderate exercise).
- Having undergone prolonged periods of forced physical inactivity during the 6 months prior to the study.
- Performing strenuous exercise during the 48 hours prior to the tests.
- Failure to replicate the same food intake on the two days of the experiments.
- Consuming caffeine or any other stimulant after 6 pm the day before the training or tests, to avoid headaches, discomfort, or lethargy among regular caffeine consumers.
- Consuming foods rich in NO3- (e.g., beetroot, spinach, or celery) during the 48 hours prior to each experimental condition.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Facultad de Medicina y Ciencias de la Salud. Universidad de Alcalá
Alcalá de Henares, Madrid, 28805, Spain
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 6, 2024
First Posted
September 19, 2024
Study Start
September 1, 2023
Primary Completion
January 30, 2024
Study Completion
May 1, 2024
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will share